CVE-2018-14787 (GCVE-0-2018-14787)
Vulnerability from cvelistv5
Published
2018-08-22 18:00
Modified
2024-09-16 18:59
Severity ?
CWE
  • CWE-269 - IMPROPER PRIVILEGE MANAGEMENT
Summary
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
References
Impacted products
Vendor Product Version
Philips IntelliSpace Cardiovascular (ISCV) products Version: IntelliSpace Cardiovascular, Version 3.1 or prior
Version: Xcelera Version 4.1 or prior
 Create a notification for this product.
Show details on NVD website

To clipboard 

{
  "containers": {
    "adp": [
      {
        "providerMetadata": {
          "dateUpdated": "2024-08-05T09:38:13.911Z",
          "orgId": "af854a3a-2127-422b-91ae-364da2661108",
          "shortName": "CVE"
        },
        "references": [
          {
            "tags": [
              "x_refsource_CONFIRM",
              "x_transferred"
            ],
            "url": "https://www.usa.philips.com/healthcare/about/customer-support/product-security"
          },
          {
            "tags": [
              "x_refsource_MISC",
              "x_transferred"
            ],
            "url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01"
          }
        ],
        "title": "CVE Program Container"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "IntelliSpace Cardiovascular (ISCV) products",
          "vendor": "Philips",
          "versions": [
            {
              "status": "affected",
              "version": "IntelliSpace Cardiovascular, Version 3.1 or prior"
            },
            {
              "status": "affected",
              "version": "Xcelera Version 4.1 or prior"
            }
          ]
        }
      ],
      "datePublic": "2018-08-14T00:00:00",
      "descriptions": [
        {
          "lang": "en",
          "value": "In Philips\u0027 IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions."
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "cweId": "CWE-269",
              "description": "IMPROPER PRIVILEGE MANAGEMENT CWE-269",
              "lang": "en",
              "type": "CWE"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2018-08-22T17:57:01",
        "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "shortName": "icscert"
      },
      "references": [
        {
          "tags": [
            "x_refsource_CONFIRM"
          ],
          "url": "https://www.usa.philips.com/healthcare/about/customer-support/product-security"
        },
        {
          "tags": [
            "x_refsource_MISC"
          ],
          "url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01"
        }
      ],
      "x_legacyV4Record": {
        "CVE_data_meta": {
          "ASSIGNER": "ics-cert@hq.dhs.gov",
          "DATE_PUBLIC": "2018-08-14T00:00:00",
          "ID": "CVE-2018-14787",
          "STATE": "PUBLIC"
        },
        "affects": {
          "vendor": {
            "vendor_data": [
              {
                "product": {
                  "product_data": [
                    {
                      "product_name": "IntelliSpace Cardiovascular (ISCV) products",
                      "version": {
                        "version_data": [
                          {
                            "version_value": "IntelliSpace Cardiovascular, Version 3.1 or prior"
                          },
                          {
                            "version_value": "Xcelera Version 4.1 or prior"
                          }
                        ]
                      }
                    }
                  ]
                },
                "vendor_name": "Philips"
              }
            ]
          }
        },
        "data_format": "MITRE",
        "data_type": "CVE",
        "data_version": "4.0",
        "description": {
          "description_data": [
            {
              "lang": "eng",
              "value": "In Philips\u0027 IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions."
            }
          ]
        },
        "problemtype": {
          "problemtype_data": [
            {
              "description": [
                {
                  "lang": "eng",
                  "value": "IMPROPER PRIVILEGE MANAGEMENT CWE-269"
                }
              ]
            }
          ]
        },
        "references": {
          "reference_data": [
            {
              "name": "https://www.usa.philips.com/healthcare/about/customer-support/product-security",
              "refsource": "CONFIRM",
              "url": "https://www.usa.philips.com/healthcare/about/customer-support/product-security"
            },
            {
              "name": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01",
              "refsource": "MISC",
              "url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01"
            }
          ]
        }
      }
    }
  },
  "cveMetadata": {
    "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
    "assignerShortName": "icscert",
    "cveId": "CVE-2018-14787",
    "datePublished": "2018-08-22T18:00:00Z",
    "dateReserved": "2018-08-01T00:00:00",
    "dateUpdated": "2024-09-16T18:59:28.155Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.1",
  "vulnerability-lookup:meta": {
    "nvd": "{\"cve\":{\"id\":\"CVE-2018-14787\",\"sourceIdentifier\":\"ics-cert@hq.dhs.gov\",\"published\":\"2018-08-22T18:29:00.340\",\"lastModified\":\"2024-11-21T03:49:47.560\",\"vulnStatus\":\"Modified\",\"cveTags\":[],\"descriptions\":[{\"lang\":\"en\",\"value\":\"In Philips\u0027 IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.\"},{\"lang\":\"es\",\"value\":\"En los productos IntelliSpace Cardiovascular (ISCV) de Phillips (ISCV en versiones 2.x o anteriores y Xcelera en versiones 4.1 y anteriores), un atacante con privilegios escalados podr\u00eda acceder a carpetas que contengan ejecutables en donde los usuarios autenticados tienen permisos de escritura, pudiendo entonces ejecutar c\u00f3digo arbitrario con permisos de administrador local.\"}],\"metrics\":{\"cvssMetricV31\":[{\"source\":\"nvd@nist.gov\",\"type\":\"Primary\",\"cvssData\":{\"version\":\"3.1\",\"vectorString\":\"CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H\",\"baseScore\":7.8,\"baseSeverity\":\"HIGH\",\"attackVector\":\"LOCAL\",\"attackComplexity\":\"LOW\",\"privilegesRequired\":\"LOW\",\"userInteraction\":\"NONE\",\"scope\":\"UNCHANGED\",\"confidentialityImpact\":\"HIGH\",\"integrityImpact\":\"HIGH\",\"availabilityImpact\":\"HIGH\"},\"exploitabilityScore\":1.8,\"impactScore\":5.9}],\"cvssMetricV2\":[{\"source\":\"nvd@nist.gov\",\"type\":\"Primary\",\"cvssData\":{\"version\":\"2.0\",\"vectorString\":\"AV:L/AC:L/Au:N/C:P/I:P/A:P\",\"baseScore\":4.6,\"accessVector\":\"LOCAL\",\"accessComplexity\":\"LOW\",\"authentication\":\"NONE\",\"confidentialityImpact\":\"PARTIAL\",\"integrityImpact\":\"PARTIAL\",\"availabilityImpact\":\"PARTIAL\"},\"baseSeverity\":\"MEDIUM\",\"exploitabilityScore\":3.9,\"impactScore\":6.4,\"acInsufInfo\":false,\"obtainAllPrivilege\":false,\"obtainUserPrivilege\":false,\"obtainOtherPrivilege\":false,\"userInteractionRequired\":false}]},\"weaknesses\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"description\":[{\"lang\":\"en\",\"value\":\"CWE-269\"}]},{\"source\":\"nvd@nist.gov\",\"type\":\"Primary\",\"description\":[{\"lang\":\"en\",\"value\":\"CWE-269\"}]}],\"configurations\":[{\"nodes\":[{\"operator\":\"OR\",\"negate\":false,\"cpeMatch\":[{\"vulnerable\":true,\"criteria\":\"cpe:2.3:a:philips:intellispace_cardiovascular:*:*:*:*:*:*:*:*\",\"versionEndIncluding\":\"3.1\",\"matchCriteriaId\":\"C11159E7-9244-49B2-933A-AAF995D4AAF6\"},{\"vulnerable\":true,\"criteria\":\"cpe:2.3:a:philips:xcelera:*:*:*:*:*:*:*:*\",\"versionEndIncluding\":\"4.1\",\"matchCriteriaId\":\"FEE47A78-BC37-427F-8B8B-81E0EB380C1C\"}]}]}],\"references\":[{\"url\":\"https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01\",\"source\":\"ics-cert@hq.dhs.gov\",\"tags\":[\"Third Party Advisory\",\"US Government Resource\"]},{\"url\":\"https://www.usa.philips.com/healthcare/about/customer-support/product-security\",\"source\":\"ics-cert@hq.dhs.gov\",\"tags\":[\"Vendor Advisory\"]},{\"url\":\"https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01\",\"source\":\"af854a3a-2127-422b-91ae-364da2661108\",\"tags\":[\"Third Party Advisory\",\"US Government Resource\"]},{\"url\":\"https://www.usa.philips.com/healthcare/about/customer-support/product-security\",\"source\":\"af854a3a-2127-422b-91ae-364da2661108\",\"tags\":[\"Vendor Advisory\"]}]}}"
  }
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.




Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or seen somewhere by the user.
  • Confirmed: The vulnerability is confirmed from an analyst perspective.
  • Exploited: This vulnerability was exploited and seen by the user reporting the sighting.
  • Patched: This vulnerability was successfully patched by the user reporting the sighting.
  • Not exploited: This vulnerability was not exploited or seen by the user reporting the sighting.
  • Not confirmed: The user expresses doubt about the veracity of the vulnerability.
  • Not patched: This vulnerability was not successfully patched by the user reporting the sighting.